Company Filing History:
Years Active: 2018
Title: Matthew Erdman: Innovator in Vaccine Development
Introduction
Matthew Erdman is a notable inventor based in Ankeny, Iowa, who has made significant contributions to the field of veterinary medicine. His innovative approach to vaccine development has the potential to enhance animal health and welfare.
Latest Patents
Erdman holds a patent for a method of rapidly producing improved vaccines for animals. This patent describes a process where a nucleic acid molecule or fragment is obtained from a biological sample of an animal exposed to a pathogenic microorganism. A protective molecule is then prepared based on this nucleic acid, which is administered to animals at risk of exposure. This method aims to elicit a protective response against the microorganism in the animal.
Career Highlights
Matthew Erdman is associated with Harrisvaccines, Inc., a company dedicated to advancing vaccine technology for animals. His work at Harrisvaccines has positioned him as a key player in the development of innovative solutions for animal health.
Collaborations
Erdman collaborates with notable colleagues, including Delbert Linn Harris and Kurt Iver Kamrud, who contribute to the research and development efforts at Harrisvaccines.
Conclusion
Matthew Erdman's contributions to vaccine development represent a significant advancement in veterinary medicine. His innovative methods have the potential to improve animal health outcomes and set new standards in the industry.